Kamryn T Eddy1,2, Jennifer J Thomas1,2, Kathryn S Brigham3,4, Laurie D Manzo3,1. 1. Eating Disorders Clinical and Research Program, Massachusetts General Hospital. 2. Department of Psychiatry, Harvard Medical School. 3. Division of Adolescent and Young Adult Medicine, Massachusetts General Hospital. 4. Department of Pediatrics, Harvard Medical School.
Abstract
PURPOSE OF REVIEW: Avoidant/restrictive food intake disorder (ARFID) was added to the psychiatric nomenclature in 2013. However, youth with ARFID often present first to medical- rather than psychiatric-settings, making its evaluation and treatment relevant to pediatricians. RECENT FINDINGS: ARFID is defined by limited volume or variety of food intake motivated by sensory sensitivity, fear of aversive consequences, or lack of interest in food or eating, and associated with medical, nutritional, and/or psychosocial impairment. It appears to be as common as anorexia nervosa and bulimia nervosa and can occur in individuals of all ages. ARFID is heterogeneous in presentation and may require both medical and psychological management. SUMMARY: Pediatricians should be aware of the diagnostic criteria for ARFID and the possibility that these patients may require medical intervention and referral for psychological treatment. The neurobiology underlying ARFID is unknown, and novel treatments are currently being tested.
PURPOSE OF REVIEW: Avoidant/restrictive food intake disorder (ARFID) was added to the psychiatric nomenclature in 2013. However, youth with ARFID often present first to medical- rather than psychiatric-settings, making its evaluation and treatment relevant to pediatricians. RECENT FINDINGS: ARFID is defined by limited volume or variety of food intake motivated by sensory sensitivity, fear of aversive consequences, or lack of interest in food or eating, and associated with medical, nutritional, and/or psychosocial impairment. It appears to be as common as anorexia nervosa and bulimia nervosa and can occur in individuals of all ages. ARFID is heterogeneous in presentation and may require both medical and psychological management. SUMMARY: Pediatricians should be aware of the diagnostic criteria for ARFID and the possibility that these patients may require medical intervention and referral for psychological treatment. The neurobiology underlying ARFID is unknown, and novel treatments are currently being tested.
Authors: Martin M Fisher; David S Rosen; Rollyn M Ornstein; Kathleen A Mammel; Debra K Katzman; Ellen S Rome; S Todd Callahan; Joan Malizio; Sarah Kearney; B Timothy Walsh Journal: J Adolesc Health Date: 2014-02-05 Impact factor: 5.012
Authors: Kamryn T Eddy; Jennifer J Thomas; Elizabeth Hastings; Katherine Edkins; Evan Lamont; Caitlin M Nevins; Rebecca M Patterson; Helen B Murray; Rachel Bryant-Waugh; Anne E Becker Journal: Int J Eat Disord Date: 2014-08-20 Impact factor: 4.861
Authors: Mary Jane De Souza; Aurelia Nattiv; Elizabeth Joy; Madhusmita Misra; Nancy I Williams; Rebecca J Mallinson; Jenna C Gibbs; Marion Olmsted; Marci Goolsby; Gordon Matheson Journal: Br J Sports Med Date: 2014-02 Impact factor: 13.800
Authors: Rollyn M Ornstein; David S Rosen; Kathleen A Mammel; S Todd Callahan; Sara Forman; M Susan Jay; Martin Fisher; Ellen Rome; B Timothy Walsh Journal: J Adolesc Health Date: 2013-05-15 Impact factor: 5.012
Authors: Ana M G A Sant'Anna; Patricia S Hammes; Mafalda Porporino; Chantal Martel; Catherine Zygmuntowicz; Maria Ramsay Journal: J Pediatr Gastroenterol Nutr Date: 2014-11 Impact factor: 2.839
Authors: Adrianne A Harris; Adrienne L Romer; Eleanor K Hanna; Lori A Keeling; Kevin S LaBar; Walter Sinnott-Armstrong; Timothy J Strauman; Henry Ryan Wagner; Marsha D Marcus; Nancy L Zucker Journal: Int J Eat Disord Date: 2019-02-25 Impact factor: 4.861
Authors: Kimberly Robelin; Peter Senada; Hassan Ghoz; Leslie Sim; Jocelyn Lebow; Michael Picco; John Cangemi; Francis A Farraye; Monia Werlang Journal: Gastroenterol Hepatol (N Y) Date: 2021-11